Johnson & Johnson Rapport Therapeutics, Inc. Transaction History
Johnson & Johnson
- $427 Million
- Q3 2025
Number of Shares
1,784,517
Previous 2,498,051
28.56%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%